F Fioredda
Overview
Explore the profile of F Fioredda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
109
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guarina A, Farruggia P, Mariani E, Saracco P, Barone A, Onofrillo D, et al.
Blood Cells Mol Dis
. 2024 Jun;
108():102860.
PMID: 38889660
Acquired aplastic anemia (AA) is a rare heterogeneous disorder characterized by pancytopenia and hypoplastic bone marrow. The incidence is 2-3 per million population per year in the Western world, but...
2.
Fioredda F, Beccaria A, Casartelli P, Turrini E, Contratto C, Giarratana M, et al.
Am J Hematol
. 2024 Jan;
99(4):534-542.
PMID: 38282561
This study identifies a new chronic form of immune neutropenia in the young with or without detectable indirect anti-neutrophil antibodies, characterized by mild/moderate neutropenia low risk of severe infection (14%),...
3.
Fioredda F, Cappelli E, Mariani A, Beccaria A, Palmisani E, Grossi A, et al.
Blood Adv
. 2019 Nov;
3(21):3432-3435.
PMID: 31714957
No abstract available.
4.
Peffault de Latour R, Peters C, Gibson B, Strahm B, Lankester A, de Heredia C, et al.
Bone Marrow Transplant
. 2015 Jun;
50(9):1168-72.
PMID: 26052913
Allogeneic hematopoietic stem cell transplantation (HSCT) offers the potential to cure patients with an inherited bone marrow failure syndrome (IBMFS). However, the procedure involves the risk of treatment-related mortality and...
5.
Castagnola E, Furfaro E, Caviglia I, Licciardello M, Faraci M, Fioredda F, et al.
Clin Microbiol Infect
. 2010 Feb;
16(8):1197-203.
PMID: 20156215
Serum galactomannan (GM) antigen detection is not recommended for defining invasive aspergillosis (IA) in children undergoing aggressive chemotherapy or allogeneic haemopoietic stem cell transplantation (HSCT). The ability of the GM...
6.
Faraci M, Cappelli B, Lanino E, Morreale G, Fioredda F, Giudice C, et al.
Pediatr Transplant
. 2008 Nov;
13(7):923-6.
PMID: 19032422
Reactivation of HBV is a well known complication in patients undergoing HSCT. Lamivudine treatment appears to prevent hepatitis B virus reactivation and to decrease the mortality in at risk HSCT...
7.
De Caro E, Fioredda F, Calevo M, Smeraldi A, Saitta M, Hanau G, et al.
Arch Dis Child
. 2005 Sep;
91(1):47-51.
PMID: 16188959
Aims: To evaluate cardiopulmonary exercise tolerance in a large cohort of apparently healthy paediatric cancer survivors in order to determine their participation in sporting activities. Methods: A total of 84...
8.
Castagnola E, Fioredda F, Barretta M, Pescetto L, Garaventa A, Lanino E, et al.
J Hosp Infect
. 2001 Jun;
48(2):142-5.
PMID: 11428882
In the period 1989-1999, Bacillus sphaericus was demonstrated to cause 12 out of 469 (2%) episodes of bacteraemia in children with cancer or receiving bone marrow transplant at G. Gaslini...
9.
Aarons L, Rowland M, Khan A, TABORELLI G, Ferrea G, Tarantino V, et al.
Eur J Pharm Sci
. 1998 Oct;
6(4):265-70.
PMID: 9795079
The population pharmacokinetics of teicoplanin in plasma and tonsillar tissue in children was determined following intramuscular administration. Thirty seven patients in all received either a single 5 mg/kg dose; 2...
10.
Fioredda F, Ranieri E, Lorusso C, Loy A, Antinozzi A, Rocca P, et al.
Pediatr Infect Dis J
. 1996 Jul;
15(7):642.
PMID: 8823868
No abstract available.